CD44 rs13347C>T Variants in 3'UTR and Prostate Neoplasms: A Case-control Study and Bioinformatics Approach.
AHR
CD44
ITGA4
microRNAs
prostate cancer
Journal
International journal of molecular and cellular medicine
ISSN: 2251-9637
Titre abrégé: Int J Mol Cell Med
Pays: Iran
ID NLM: 101598104
Informations de publication
Date de publication:
2023
2023
Historique:
received:
28
02
2024
revised:
16
04
2024
accepted:
17
04
2024
medline:
1
1
2023
pubmed:
1
1
2023
entrez:
16
5
2024
Statut:
ppublish
Résumé
CD44, a cell-surface receptor and a key player in cellular signaling, can act as both tumor suppressor and promoter. This study aimed to investigate the association of
Identifiants
pubmed: 38751654
doi: 10.22088/IJMCM.BUMS.12.3.275
pmc: PMC11092902
doi:
Types de publication
Journal Article
Langues
eng
Pagination
275-287Informations de copyright
© The Author(s).